Peer Review History
| Original SubmissionMay 20, 2025 |
|---|
|
Dear Dr. Liu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 10 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Gbolahan Deji Olatunji, M.D, MPH Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: [This research was funded by the Noncommunicable Chronic Diseases-National Science and Technology Major Project (NO. 2023ZD0507400, 2023ZD0507401, 2023ZD0507403), National Natural Science Foundation of Jiangsu Province (NO. BK20220708) and National Natural Science Foundation of China (NO. 82170837, 82230028, 82404271).]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: I Don't Know Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: Major Concerns: The cross-sectional design cannot support the causal language used throughout the manuscript. Terms like "beneficial," "improving," and recommendations to "increase consumption" are inappropriate for observational data. The title claiming "Improved Carbohydrate Quality" overstates what can be concluded from cross-sectional associations. Critical statistical information is missing from the analysis. The authors report no effect sizes for key findings, provide no confidence intervals for primary outcomes, and include no power calculations or sample size justifications. Multiple testing corrections were not applied despite numerous dietary variable comparisons. The methodological rigor is insufficient for publication standards. The CGM monitoring period of only 3 days falls below current standards requiring ≥14 days for reliable metrics. Missing data handling procedures are not described, and LightGBM cross-validation methods are inadequately documented. Data Availability Issues: The manuscript does not comply with PLOS data availability requirements. Despite claiming "all relevant data are within the manuscript," only summary statistics are provided. Individual-level data, raw CGM measurements, and machine learning datasets required by PLOS policy are missing. Technical Problems: The sample size of 65 participants for CGM analysis is insufficient for robust meal-specific conclusions. Selection bias from clinic-based recruitment is inadequately addressed. There is temporal mismatch between dietary assessment periods and CGM monitoring. Key confounders including medication adherence and socioeconomic factors are not controlled. Required Revisions: All conclusions must be reframed using associational rather than causal language. Effect sizes with confidence intervals must be reported for all key findings. Design limitations must be acknowledged prominently in the abstract and conclusions. Clinical recommendations inappropriate for observational data must be removed. Complete individual-level datasets must be provided per PLOS policy requirements. The research question is clinically relevant and the statistical approaches are sophisticated. However, the fundamental mismatch between study design capabilities and conclusions drawn prevents acceptance. Major revisions addressing these core methodological and reporting issues are required before this work can meet publication standards. Reviewer #2: 1. The current title does not fully capture the scope and analytical depth of the study. While it accurately reflects the general finding, it overlooks key aspects such as the study design (cross-sectional), the use of both FFQ and 3-day meal-based dietary records, and the incorporation of CGM-derived glycemic variability metrics analyzed through mixed-effects and machine learning models. I recommend revising the title to better reflect these methodological components and provide a clearer picture of the study at a glance. A more appropriate and informative title might be: “Association Between Carbohydrate Quality and Glycemic Control in Individuals with Type 1 Diabetes: A Cross-Sectional and Meal-Based Analysis” Or “Carbohydrate Quality and Glycemic Outcomes in Type 1 Diabetes: Evidence from Cross-Sectional and Meal-Level Data Analyses” 2. The association between higher dietary protein intake and elevated HbA1c levels (Tables 2 and 3) contrasts with existing literature that suggests protein intake is typically neutral or beneficial for glycemic control in T1D. The discussion should address possible explanations for this discrepancy, including residual confounding, differences in protein source (e.g., animal vs. plant), dietary context, or reverse causality (e.g., individuals with poor control increasing protein intake following clinical advice). 3. The interpretation of the MCA results suggests an association between high-quality carbohydrate intake and better glycemic control. It should be emphasized that these findings are observational and do not imply causality due to the cross-sectional design. Clarify whether the dietary variables independently contributed to quadrant clustering or whether other unmeasured factors may have influenced the patterns. 4. Misclassification bias should be acknowledged as a limitation. Despite using validated tools, self-reported dietary data—especially regarding portion sizes, meal timing, and food type classification—are subject to error and may affect the observed associations. 5. There is no table in the manuscript or supplementary materials that clearly presents the demographic and clinical characteristics of the study participants (e.g., age range, gender distribution, BMI, diabetes duration, insulin regimen). This information is essential for evaluating the generalizability and context of the findings. Please include a table in the main text or supplementary materials summarizing these baseline characteristics. Reviewer #3: I commend the authors' work in evaluating the association between improved carbohydrate quality and better glycemic control in individuals with Tye 1 Diabetes. Please find my comments below: -line 29: Please replace "established" with "used" to describe the utilization of LightGBM model in the analysis -line 77: Please replace "dietary intake" with "the quality of carbohydrates in the diet" which better describes the aim of the study -line 87: Exclusion criteria: Did the authors consider hypothyroidism specifically, given the association between hypothyroidism and Type 1 Diabetes? -lines 100 - 101: "Subsequently, a total of 65 patients maintained a 3-day food record..." Are there specific criteria for selecting the 65 participants who maintained a 3-day food record and wore the CGM? Please include the method of section in the manuscript. -line 101: mentioned that these 65 participants wore the CGM: How long were participants expected to wear the CGM? Did all participants wear the CGM for the same length of time? Please include this information in the manuscript. -lines 119-124: described various analysis performed. Was there additional analysis to test for multicollinearity among the independent variables? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: ELOHOR OBOREVWORI Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Liu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 10 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Gbolahan Deji Olatunji, M.D, MPH Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: Yes ********** Reviewer #1: Overall Assessment: This manuscript presents a well-designed observational study examining the association between carbohydrate quality and glycemic control in individuals with Type 1 diabetes. The authors have addressed previous reviewer concerns and the work makes a meaningful contribution to diabetes nutrition research. Strengths: 1. Novel methodology: The combination of FFQ data with real-time CGM monitoring provides both long-term dietary patterns and immediate glycemic responses. This represents a significant advance over previous studies. 2. Statistical rigor: The mixed-effects models properly handle the hierarchical data structure. The addition of machine learning (LightGBM) with SHAP analysis strengthens the analytical approach. 3. Clinical relevance: The focus on carbohydrate quality rather than quantity aligns with current diabetes management guidelines and provides practical insights for clinical care. 4. Language revision: The authors have successfully modified conclusions to reflect associational rather than causal relationships, which shows good scientific judgment. Technical Soundness: The statistical methodology is sound. The mixed-effects models properly account for within-subject correlation, and the adjustment for confounders strengthens the validity of findings. The sample size (n=155 for FFQ, n=65 for CGM analysis with 538 meals) is adequate for the analyses performed. Data Availability: The authors have fully complied with PLOS ONE data sharing requirements by providing complete individual-level datasets in the Supporting Information files. This allows for reproduction of all analyses. Language Issues Requiring Correction: 1. Line 119-120: "During the CGM period, participants completed three 24-hour dietary records�included 2 weekdays and 1 weekend day" - Replace Chinese comma with semicolon and change "included" to "including" 2. Line 367: Keep "HbA1c" formatting consistent throughout (avoid subscript variations) 3. General: Replace remaining Chinese punctuation marks (�) with standard English punctuation Scientific Comments: 1. Effect sizes: While statistically significant, some associations (e.g., fiber OR=1.101) are modest. The clinical significance could be better explained. 2. Lunch findings: The observation that glycemic variability is highest at lunch is interesting and deserves further investigation in future studies. 3. Study population: Results from this Chinese population may not apply directly to other ethnic groups. This limitation is properly acknowledged. Suggestions: 1. Consider discussing the practical challenges of increasing whole grain consumption in this population. 2. The protein-HbA1c association, while well-explained, could benefit from additional investigation in future work. 3. Future studies might use biochemical markers (e.g., alkylresorcinols) to validate self-reported whole grain intake. Conclusion: This manuscript represents solid observational research that advances our understanding of carbohydrate quality effects in T1D management. The methodology is sound, the statistical analysis is rigorous, and the conclusions are properly drawn with acknowledgment of limitations. The work supports current dietary guidelines while providing new insights into meal-specific glycemic effects. Reviewer #3: I commend the authors' work. Thank you for addressing previous comments and for the detailed response. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: ELOHOR OBOREVWORI Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Dear Dr. Liu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Gbolahan Deji Olatunji, M.D, MPH Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #4: All comments have been addressed Reviewer #5: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Partly Reviewer #4: Partly Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #4: I Don't Know Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #4: Yes Reviewer #5: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #4: Yes Reviewer #5: Yes ********** Reviewer #1: This manuscript examines carbohydrate quality and glycemic control in Type 1 diabetes using food frequency questionnaires and synchronized dietary records with CGM. The research question is clinically relevant, but critical statistical issues require correction before publication. Critical Issues Multiple Testing: The analysis tests approximately 8 dietary variables × 5 outcomes × 3 meals without correction for multiple comparisons. With approximately 120 tests at α=0.05, approximately 6 false positives are expected by chance alone. The authors must either apply Bonferroni, Holm, or false discovery rate correction, or explicitly acknowledge this as exploratory hypothesis-generating research requiring confirmation. Several associations with p-values between 0.01-0.05 may be statistical artifacts. LightGBM Validation: R²=95-96% suggests potential overfitting. The manuscript provides no cross-validation details (split-sample? k-fold? leave-one-out?). With only 65 subjects and 17 features, overfitting is highly likely. The authors must document proper validation methodology or remove this section. The SHAP analysis conclusions cannot be trusted without demonstrated generalization. Mixed-Effects Specification: The manuscript states mixed-effects models were used but doesn't fully specify random effects structure. For nested data (meals within days within persons), the authors must state whether random slopes are included, what correlation structure is assumed, and provide complete model specifications. Unmeasured Confounding: The models omit insulin delivery method, carbohydrate counting accuracy, hypoglycemia treatment behaviors, and socioeconomic status—all plausible confounders of observed associations. A discussion paragraph explicitly acknowledging these unmeasured confounders is required. Missing Data: Line 148 mentions "multiple imputation" with no supporting details. The manuscript must specify which variables had missing data, what percentage was missing, how many imputations were performed, and what imputation model was used. Sample Size: With only 65 participants for 3-day records and 188 lunch observations, statistical power is limited for several analyses. The authors should quantify which specific analyses are underpowered, as null findings may reflect insufficient power rather than true absence of effects. Moderate Issues Protein Discussion: Lines 361-385 provide extensive mechanistic speculation beyond what the cross-sectional data can support. Reverse causation (poor glycemic control leading to altered protein intake) is equally plausible but not adequately discussed. This section should be condensed or alternative explanations presented with equal weight. Whole Grain Classification: The methodology for categorizing foods as whole versus refined grain is not described. Whether based on composition tables, package labels, or participant self-report substantially affects interpretation. Misclassification of mixed-grain products could drive observed associations. Effect Size Interpretation: OR=1.101 for fiber would imply implausibly large effects across the full intake range from current (10.3g) to recommended (25-36g) levels. The discussion should more explicitly address non-linearity possibilities and residual confounding. Lunch Findings: The observation that lunch shows highest glycemic variability despite having highest fiber intake (alongside highest GI/GL) represents an internal inconsistency deserving discussion. Alternative explanations including diurnal insulin sensitivity patterns, meal location, or bolus timing should be considered. Minor Corrections Line 120: "records; including" should be "records, including" (incorrect semicolon usage) Line 299: "Fragile diabetes stage" is non-standard terminology—define clearly or use standard terms Lines 418-422: This 85-word sentence should be broken into 2-3 shorter sentences A data dictionary describing contents of datasets.zip would improve data reusability Consider adding subheadings in results section for improved organization Summary The methodology is generally appropriate for observational research and the synchronized dietary-CGM approach represents a strength. However, statistical deficiencies—particularly the multiple testing problem and inadequate model validation—substantially undermine confidence in specific findings. These issues are correctable through revised methods and discussion sections rather than requiring new analyses. With appropriate statistical corrections and appropriately tempered conclusions, this manuscript would represent solid hypothesis-generating research for future intervention trials. Reviewer #4: Dear Author The most critical limitations and methodological flaws of your study are summarized concisely below: * Cross-Sectional Design (No Causation): The study design only permits the establishment of an association between carbohydrate quality (fiber/whole grains) and glycemic control {HbAc). It cannot prove causality; the direction of the relationship is unclear. * Reliance on Self-Reported Data: Dietary intake, assessed via FFQs and 3-day records, is prone to recall bias and measurement error. Patients may misreport consumption, potentially exaggerating the health benefits observed. * Lack of Objective Validation: The study did not utilize objective biomarkers (such as alkylresorcinols) to confirm the self-reported whole grain intake, which is a key limitation in precisely assessing the dietary exposure. * Limited Generalizability: The findings may be restricted to the specific ethnic/regional population studied and might not be directly applicable to Type 1 Diabetes patients in other parts of the world with different dietary habits. Reviewer #5: The present study investigates real-world data on dietary habits and their influence on glucose profiles in individuals with type 1 diabetes (T1D). The topic is relevant and the study is methodologically sound. However, several minor revisions would further improve the clarity and overall scientific quality of the manuscript: - The term “patients” should be avoided to ensure the use of inclusive language throughout the text. Please replace it with consistent terms such as “individuals,” “people,” or “participants.” - Lines 65–68: The sentence appears confusing. A long-term low-carbohydrate diet cannot increase the risk of diabetes onset in individuals already diagnosed with T1D. Please revise this statement for accuracy and clarity. - Line 82: The sentence “155 patients diagnosed with T1D were enrolled” should appear only in the Results section. Additionally, sentences should not begin with Arabic numerals. - To strengthen the scientific depth of the discussion, the authors are encouraged to elaborate on the following aspects: The influence of major factors affecting postprandial glucose levels and metabolism, particularly the role of macronutrients and other dietary and lifestyle factors (doi: 10.1038/s41430-023-01359-8); The association between daily carbohydrate (CHO) entries and glycemic outcomes, especially among users of automated insulin delivery systems (doi: 10.2337/dc25-0283). - Some figures (e.g., Figures 2b, 2c, and 5) appear blurry. Please improve image resolution and graphical quality to enhance readability. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: ELOHOR OBOREVWORI Reviewer #4: No Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 3 |
|
Association Between Carbohydrate Quality and Glycemic Control in Individuals with Type 1 Diabetes: A Cross-Sectional and Meal-Based Analysis PONE-D-25-25262R3 Dear Dr. Liu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Gbolahan Deji Olatunji, M.D, MPH Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #5: All comments have been addressed Reviewer #6: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #5: Yes Reviewer #6: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #5: Yes Reviewer #6: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #5: Yes Reviewer #6: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #5: Yes Reviewer #6: Yes ********** Reviewer #5: I appreciated the authors' efforts to address all the comments received. The manuscript has greatly improved after the revision. No further comments from my side. Reviewer #6: The authors revised well to the reviewers' comments. This reviewer has no further comments to this article. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #5: No Reviewer #6: Yes: Yoshitaka Hashimoto ********** |
| Formally Accepted |
|
PONE-D-25-25262R3 PLOS One Dear Dr. Liu, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Gbolahan Deji Olatunji Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .